Literature DB >> 31773452

Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line.

Peiyu Jin1, Jieyu Liu1, Qing Zhou1, Sihao Li1, Weijue Liu1, Shuhua Xi2.   

Abstract

Entities:  

Keywords:  Arsenite; Cell proliferation; Human Epidermal Growth Factor Receptor; Urothelium

Mesh：

Substances：

Year:  2019        PMID： 31773452     DOI： 10.1007/s10565-019-09500-9

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN： 0742-2091            Impact factor:   6.691


× No keyword cloud information.
  23 in total

1.  Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina.

Authors:  Laura Rosana Aballay; María del Pilar Díaz; Franco Matías Francisca; Sonia Edith Muñoz
Journal:  Int J Environ Health Res       Date:  2011-10-24       Impact factor: 3.411

2.  The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation.

Authors:  Abdo J Najy; Kathleen C Day; Mark L Day
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

3.  Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities - Part 1.

Authors:  Debasis Das; Lingzhi Xie; Jingbing Wang; Xin Xu; Zonghua Zhang; Jingli Shi; Xiaoyong Le; Jian Hong
Journal:  Bioorg Med Chem Lett       Date:  2018-12-24       Impact factor: 2.823

4.  Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma.

Authors:  Jia-Bin Liao; Huai-Pao Lee; Hsiao-Ting Fu; Herng-Sheng Lee
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-07

5.  Rapid screening of drug candidates against EGFR/HER2 signaling pathway using fluorescence assay.

Authors:  Farkhondeh Khanjani; Reza H Sajedi; Sadegh Hasannia
Journal:  Anal Bioanal Chem       Date:  2018-10-18       Impact factor: 4.142

6.  HER2 signaling regulates HER2 localization and membrane retention.

Authors:  Jaekwang Jeong; Wonnam Kim; Lark Kyun Kim; Joshua VanHouten; John J Wysolmerski
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

Review 7.  Role of ErbB Receptors in Cancer Cell Migration and Invasion.

Authors:  Aline Appert-Collin; Pierre Hubert; Gérard Crémel; Amar Bennasroune
Journal:  Front Pharmacol       Date:  2015-11-24       Impact factor: 5.810

Review 8.  The Mysterious Ways of ErbB2/HER2 Trafficking.

Authors:  Vibeke Bertelsen; Espen Stang
Journal:  Membranes (Basel)       Date:  2014-08-06

9.  Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.

Authors:  M C Kriegmair; R M Wirtz; T S Worst; J Breyer; M Ritter; B Keck; C Boehmer; W Otto; M Eckstein; C A Weis; A Hartmann; C Bolenz; P Erben
Journal:  Transl Oncol       Date:  2018-02-23       Impact factor: 4.243

10.  Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.

Authors:  Ines De Pauw; Filip Lardon; Jolien Van den Bossche; Hasan Baysal; Erik Fransen; Vanessa Deschoolmeester; Patrick Pauwels; Marc Peeters; Jan Baptist Vermorken; An Wouters
Journal:  Mol Oncol       Date:  2018-05-01       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.